Uxin, Sesen Bio, Dermata Therapeutics And More: U.S. Stocks To Watch

Benzinga2022-12-30

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

Uxin Limited (NASDAQ:UXIN) is expected to report its unaudited financial results for the second quarter of fiscal year 2023 before the opening bell. Uxin shares gained 4.4% to $3.30 in the after-hours trading Thursday.
Mesa Air Group, Inc. (NASDAQ:MESA) reported a wider-than-expected loss for its fourth quarter, while sales topped estimates. Mesa Air shares dropped 2.2% to $1.32 in after-hours trading Thursday.
Heidrick & Struggles International, Inc. (NASDAQ:HSII) agreed to acquire Atreus for $61 million. Heidrick & Struggles shares gained 1.5% to $28.92 in after-hours trading Thursday.

Sesen Bio, Inc. (NASDAQ:SESN) and Carisma Therapeutics reported an increased special dividend of approximately $0.34 per share, in connection with the pending merger. Sesen Bio shares surged 26.2% to $0.6376 in premarket trading Friday.
Dermata Therapeutics, Inc. (NASDAQ:DRMA) requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Dermata Therapeutics shares jumped 110% to $0.42 in premarket trading Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

tplian
2022-12-30
tplian
Ok
Rjn828
2022-12-30
Rjn828
Surprised
Singman
2022-12-30
Singman
Like
Zarkness
2022-12-30
Zarkness
👋

Leave a comment

4

63

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2295798099?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-12-30 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2295798099","market":"us","top_or_hot":-1,"title":"Uxin, Sesen Bio, Dermata Therapeutics And More: U.S. Stocks To Watch","media":"Benzinga","content":"<html><head></head><body><p>With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:</p><ul><li><b>Uxin Limited</b> (NASDAQ:UXIN) is expected to report its unaudited financial results for the second quarter of fiscal year 2023 before the opening bell. Uxin shares gained 4.4% to $3.30 in the after-hours trading Thursday.</li><li><b><a href=\"https://laohu8.com/S/MESA\">Mesa Air Group, Inc.</a></b> (NASDAQ:MESA) reported a wider-than-expected loss for its fourth quarter, while sales topped estimates. Mesa Air shares dropped 2.2% to $1.32 in after-hours trading Thursday.</li><li><b>Heidrick &amp; Struggles International, Inc.</b> (NASDAQ:HSII) agreed to acquire Atreus for $61 million. Heidrick &amp; Struggles shares gained 1.5% to $28.92 in after-hours trading Thursday.</li></ul><ul><li><b><a href=\"https://laohu8.com/S/SESN\">Sesen Bio, Inc.</a></b> (NASDAQ:SESN) and Carisma Therapeutics reported an increased special dividend of approximately $0.34 per share, in connection with the pending merger. Sesen Bio shares surged 26.2% to $0.6376 in premarket trading Friday.</li><li><b><a href=\"https://laohu8.com/S/DRMA\">Dermata Therapeutics, Inc.</a></b> (NASDAQ:DRMA) requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Dermata Therapeutics shares jumped 110% to $0.42 in premarket trading Friday.</li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Uxin, Sesen Bio, Dermata Therapeutics And More: U.S. Stocks To Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUxin, Sesen Bio, Dermata Therapeutics And More: U.S. Stocks To Watch\n</h2>\n\n<h4 class=\"meta\">\n\n2022-12-30 17:26 北京时间&nbsp;&nbsp;&nbsp;<strong>Benzinga</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:Uxin Limited (NASDAQ:UXIN) is expected to report its unaudited ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UXIN","symbol_name":"优信","start_time":0,"source_url":"","article_id":"2295798099","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2295798099","pubTimestamp":1672392370,"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:\n","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UXIN":"优信","BK4130":"人力资源与就业服务","BK4007":"制药","DRMA":"Dermata Therapeutics Inc","BK4122":"互联网与直销零售","BK4539":"次新股","HSII":"海德思哲服务","BK4563":"昨日强势股","BK4008":"航空公司","BK4505":"高瓴资本持仓","MESA":"Mesa Air Group, Inc.","BK4139":"生物科技","BK4500":"航空公司"},"translate_title":"Uxin、Sesen Bio、Dermata Therapeutics等：值得关注的美国股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HSII":1,"UXIN":1,"DRMA":0.9,"MESA":0.9,"SESN":0.9},"content_text":"With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:Uxin Limited (NASDAQ:UXIN) is expected to report its unaudited financial results for the second quarter of fiscal year 2023 before the opening bell. Uxin shares gained 4.4% to $3.30 in the after-hours trading Thursday.Mesa Air Group, Inc. (NASDAQ:MESA) reported a wider-than-expected loss for its fourth quarter, while sales topped estimates. Mesa Air shares dropped 2.2% to $1.32 in after-hours trading Thursday.Heidrick & Struggles International, Inc. (NASDAQ:HSII) agreed to acquire Atreus for $61 million. Heidrick & Struggles shares gained 1.5% to $28.92 in after-hours trading Thursday.Sesen Bio, Inc. (NASDAQ:SESN) and Carisma Therapeutics reported an increased special dividend of approximately $0.34 per share, in connection with the pending merger. Sesen Bio shares surged 26.2% to $0.6376 in premarket trading Friday.Dermata Therapeutics, Inc. (NASDAQ:DRMA) requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering. Dermata Therapeutics shares jumped 110% to $0.42 in premarket trading Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9927364422,"gmtCreate":1672402125066,"gmtModify":1676538685758,"author":{"id":"4108629412181280","authorId":"4108629412181280","name":"tplian","avatar":"https://community-static.tradeup.com/news/7ecc0302d7a6f2cd28a1199a63498645","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4108629412181280","authorIdStr":"4108629412181280"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927364422","repostId":2295798099,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9927361969,"gmtCreate":1672401086052,"gmtModify":1676538685594,"author":{"id":"3583839588979540","authorId":"3583839588979540","name":"Rjn828","avatar":"https://static.tigerbbs.com/16e7a5cec19c9e23b54723e33e43d828","vip":1,"crmLevel":4,"crmLevelSwitch":1,"idStr":"3583839588979540","authorIdStr":"3583839588979540"},"htmlText":"Surprised&nbsp;","listText":"Surprised&nbsp;","text":"Surprised","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927361969","repostId":2295798099,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9927316063,"gmtCreate":1672396473552,"gmtModify":1676538684843,"author":{"id":"3575125836760247","authorId":"3575125836760247","name":"Singman","avatar":"https://static.tigerbbs.com/d770feb757705f2d631d2d5f381ae07b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575125836760247","authorIdStr":"3575125836760247"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927316063","repostId":2295798099,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9927337628,"gmtCreate":1672394854665,"gmtModify":1676538684552,"author":{"id":"3572916667219493","authorId":"3572916667219493","name":"Zarkness","avatar":"https://static.tigerbbs.com/4b8c61830c4883c4232aece921d89d14","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0,"idStr":"3572916667219493","authorIdStr":"3572916667219493"},"htmlText":"👋&nbsp;","listText":"👋&nbsp;","text":"👋","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9927337628","repostId":2295798099,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":63,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2295798099"}